Ellevest, Inc. Esperion Therapeutics, Inc. Transaction History

Ellevest, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	SELL	$5.09 - $8.5 $432 - $722	-85 Reduced 19.54%	350 $2,000
Q3 2022 Nov 02, 2022	BUY	$5.45 - $8.13 $234 - $349	43 Added 10.97%	435 $3,000
Q2 2022 Jul 18, 2022	SELL	$4.77 - $6.67 $200 - $280	-42 Reduced 9.68%	392 $2,000
Q1 2022 Apr 19, 2022	BUY	$3.34 - $5.56 $1,158 - $1,929	347 Added 398.85%	434 $2,000
Q4 2021 Jan 24, 2022	BUY	$4.81 - $11.92 $52 - $131	11 Added 14.47%	87 $0
Q3 2021 Oct 19, 2021	BUY	$11.34 - $21.37 $861 - $1,624	76 New	76 $1,000

207

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $168M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.